The US Department of Justice (DOJ) conducted an investigation into implantable cardioverter-defibrillators (ICDs) not meeting the Centers for Medicare & Medicaid Services National Coverage Determination (NCD) criteria.
R andomized clinical trials have demonstrated that implantable cardioverter-defibrillators (ICDs) improve the survival of selected patients at increased risk of sudden cardiac death. [1] [2] [3] The pivotal trials for primary prevention (implanted in individuals at increased risk for ventricular arrhythmias and sudden cardiac death) ICDs excluded patients who had a recent acute myocardial infarction or coronary revascularization, and both newly diagnosed and advanced heart failure. Moreover, other clinical trials failed to demonstrate a survival benefit with ICDs placed prophylactically among patients undergoing coronary artery bypass graft (CABG) surgery or early after an acute myocardial infarction. [4] [5] [6] In 2005, the Centers for Medicare & Medicaid Services (CMS) developed a National Coverage Determination (NCD) for ICDs, which incorporated this information and aligned payment for primary prevention ICD implants with the available clinical evidence. [7] [8] [9] In 2010, the US Department of Justice (DOJ) notified hospitals of an investigation into potential overuse of ICDs in violation of the False Claims Act; the existence of the investigation was made public in January 2011. Contemporaneously, a study demonstrated that 22.5% of primary prevention devices were not aligned with NCD criteria. 10 By February 2016, the DOJ concluded its investigation, reaching settlements with more than 500 hospitals that exceeded $280 million.
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The purpose of this study was to examine whether the proportion of initial primary prevention ICDs that did not meet the CMS NCD criteria changed following the announcement of the DOJ investigation and whether trends varied among hospitals that did reach settlements in the investigation (settlement hospitals) and those that did not (nonsettlement hospitals). In addition, changes in the volume of initial secondary prevention ICDs (implanted in individuals with a history of sustained ventricular arrhythmia or cardiac arrest) were assessed as a potential signal of unintended consequences of the DOJ investigation.
Methods

Data Source
Details of the National Cardiovascular Data Registry (NCDR)-ICD Registry have been described previously. 14, 15 In brief, the registry was created to satisfy a reimbursement requirement from CMS for primary prevention ICDs and has more than 1800 participating hospitals. It includes detailed information collected by trained staff using a standardized data collection form. 16 Data submissions must meet specified quality standards and randomly identified sites are subject to audits. 17 The
Human Investigation Committee of the Yale University School of Medicine approved the use of a limited data set from the NCDR for research and granted a waiver of informed consent.
US Department of Justice Investigation
The DOJ investigation began in 2008 with the submission of a whistle-blower complaint against approximately 1300 hospitals under the False Claims Act (eFigure 1 in the Supplement). Hospitals were notified of an investigation of ICDs that did not meet NCD criteria starting in early 2010 when the DOJ sent civil investigative demands. 13, 18 In January 2011, the Heart Rhythm Society notified its members of the active DOJ investigation and released a public statement on the investigation. 19 In October 2015, 
Outcomes
The primary outcome was the proportion of initial primary prevention ICD implantations among Medicare beneficiaries that did not meet CMS NCD criteria at each 6-month interval. ICDs not meeting the NCD criteria were identified using methods and definitions applied in prior analyses. 10 Specifically, among
Medicare beneficiaries with prior myocardial infarction and ejection fraction less than or equal to 30% or any congestive heart failure and ejection fraction less than or equal to 35%, patients were classified as receiving an ICD that did not meet NCD criteria for the following reasons: the individual (1) had a myocardial infarction within 40 days before ICD implantation; (2) had CABG surgery within 3 months before ICD implantation; (3) had New York Heart Association class IV symptoms without receiving concomitant cardiac resynchronization therapy; or (4) had newly diagnosed heart failure at the time of ICD implantation. 7, 10 Additional outcomes included the volume of initial primary and secondary prevention ICDs over time and the proportion of initial primary prevention ICDs not meeting the CMS NCD criteria among non-Medicare beneficiaries.
Statistical Analysis
All analyses were performed either at the patient level or the hospital level. For patient-level analyses, all primary prevention ICD implantations were included. Records lacking documentation of the data elements required to determine whether the ICD met the CMS NCD criteria as well as those from hospitals that did not meet the NCDR data quality standards were excluded from the analysis. Baseline demographic and clinical characteristics were compared between settlement hospitals and nonsettlement hospitals. The proportion of ICDs that did not meet CMS NCD criteria were calculated for each 6-month interval and compared over time, stratified by hospital settlement group.
To examine associations with the DOJ investigation, we used an interrupted time series to investigate changes in the proportion of ICDs not meeting the NCD criteria. This nonexperimental design is often used to estimate the associations with a policy intervention or other natural experiment provided there are at least 4 data points both before and after the event of interest. 20, 21 The interrupted time series model was fit using a linear probability autoregressive model. We calculated estimates of the proportion of ICDs not meeting CMS NCD criteria during each month accounting for seasonal autocorrelation stratified by DOJ settlement status. Based on the timing of hospital notification of the DOJ investigation, the model was designed to evaluate 3 periods: before the DOJ investiga- For hospital-level analyses, we required hospitals to have participated in the NCDR ICD Registry over the entire study period, and to have performed at least 10 primary prevention ICD implants in each year. 10 Baseline hospital characteristics were compared with standardized differences. The proportion of ICDs that did not meet the CMS NCD was determined by aggregating all primary prevention ICDs among Medicare beneficiaries in the calendar year to calculate a hospital-specific estimate, again stratifying by the hospital's settlement status, and displayed using box plots. Top and bottom performing hospitals were defined as facilities in the first and fourth quartile of performance. The volume of initial primary and secondary prevention ICDs was examined over time, stratifying by DOJ settlement status. The patient-level and hospitallevel analyses were repeated among non-Medicare beneficiaries to determine whether the DOJ investigation affected the broader population of patients undergoing ICD implantation.
As a negative control to assess how secular changes might have affected associations of the DOJ investigation with practice patterns, we examined the volume of ICD generator changes for the end of battery life and device upgrades (single-chamber to dual-chamber ICD or ICD to cardiac resynchronization therapy device) over the study period. For this analysis, we included implants in Medicare beneficiaries performed at hospitals continuously participating in the ICD Registry and performing at least 1 such case in each year. These implants were performed for welldefined populations and clinical indications that were independent of the NCD and therefore would provide additional insight into whether the observed changes among primary prevention ICDs were consistent with secular trends in procedural utilization or represented direct associations with the DOJ investigation.
All analyses were conducted using SAS software (SAS Institute), version 9.4. All tests for statistical significance were 2-tailed and evaluated with a P value less than .05 for significance.
Results
There were a total of 309 850 initial primary prevention ICDs in Medicare beneficiaries across 1810 hospitals between January 1, 2007, and December 31, 2015, in the NCDR ICD Registry. A total of 9699 device implants and 1 hospital were excluded from the analysis due to incomplete data, yielding a study cohort of 300 151 primary prevention ICDs at 1809 hospitals ( Figure 1 ). Of the 470 hospitals that had reached settlements with the DOJ and were matched to the NCDR ICD Registry, 2 were confirmed as having closed and 16 did not submit data or their data did not meet NCDR quality standards. Settlement hospitals (n = 452) implanted 99 591 primary prevention ICDs whereas nonsettlement hospitals (n = 1357) implanted 200 560 primary prevention ICDs. Hospital-level analyses included a total of 505 hospitals (180 settlement hospitals and 325 nonsettlement hospitals) and 200 558 ICDs (71 467 at settlement hospitals and 129 091 at nonsettlement hospitals).
Baseline Characteristics
Demographic and clinical characteristics of patients undergoing ICD implantation at settlement hospitals and nonsettlement hospitals are shown in the Table. The mean age was 75.1 years (SD, 6.3), 71.5% were men, 41.8% had diabetes, 54.4% had a prior myocardial infarction, and the mean ejection fraction was 25.0% (SD, 6.2%). The majority of patients received CRT defibrillator devices (53.0%) with 28.9% receiving dual-chamber ICDs and 18.2% receiving single-chamber ICDs. There were no clinically meaningful differences between patients receiving ICDs at settlement hospitals compared with nonsettlement hospitals. Additional hospital characteristics are provided in eTable 1intheSupplement. Settlement hospitals were larger, private facilities with higher procedural volumes, and were more likely located in the South and West geographic regions.
ICDs That Did Not Meet NCD Criteria Among Medicare Beneficiaries
The proportion of ICDs that did not meet the CMS NCD criteria at the patient level is displayed in 6-month intervals in Figure 2 . In the first half of 2007, 25.8% (95% CI, 24.7% to 26.8%) of ICD implants at hospitals that reached settlements with the DOJ and 22.8% (95% CI, 22.1% to 23.5%) of ICDs at nonsettlement hospitals did not meet the NCD criteria (P < .001). Over the study period, there was a statistically significant 62.7% (95% CI, 59.2% to 66.1%) relative decrease and 16.1% (95% CI, 14.8% to 17.5%) absolute decrease in ICDs not meeting the NCD criteria at settlement hospitals and a 53.2% (95% CI, 50.4% to 56.0%) relative decrease and a 12.1% (95% CI, 11.2% to 13.0%) absolute decrease at nonsettlement hospitals (P < .001 for both; P for interaction < .001).
These overall changes are attributable to 3 distinct trends illustrated in the interrupted time series analysis ( Figure 2A ). From January 2007 through December 2009, the period before the announcement of the DOJ investigation, the proportion of primary prevention ICDs not meeting NCD criteria was relatively stable and the rate of decline was modest and similar among hospital settlement groups (annualized change: −1.1% [95% CI, −1.7% to −0.5%] among settlement hospitals vs −0.4% [−1.0% to 0.2%] among nonsettlement hospitals; P for interaction = .10). From January 2010 through July 2011, there were significant decreases in the proportion of ICDs not meeting the NCD criteria among both hospital settlement groups. However, the rate of decline was significantly larger and more rapid at settlement hospitals compared with nonsettlement hospitals (annualized change: −7.4% [−8.9% to −5.9%] among settlement hospitals vs −4.7% [−6.2% to −3.2%] among nonsettlement hospitals; P for interaction = .01). From July 2011 through December 2015, the proportion of ICDs not meeting the NCD criteria were similar and stable in both hospital settlement groups with an annual change of −0.5% (95% CI, −0.9% to −0.2%) for settlement hospitals and −0.4% (95% CI, −0.8% to −0.1%) for nonsettlement hospitals (P for interaction = .71).
Trends in the proportion of ICDs not meeting the NCD criteria at the hospital level were similar to patient-level trends (eFigure 2 in the Supplement). Although there were significant decreases in ICDs not meeting the NCD criteria, there was persistent variation in performance in 2015 with topperforming facilities having less than 3.8% of ICDs not meeting the NCD criteria whereas lower-performing hospitals had more than 14.3% of ICDs not meeting the NCD criteria.
ICDs That Did Not Meet NCD Criteria Among Non-Medicare Beneficiaries
Trends in the proportion of primary prevention ICDs not meeting the NCD criteria among non-Medicare beneficiaries stratified by hospital settlement group were similar to those among c These 452 hospitals settled with the DOJ and were included in the study cohort. The DOJ announced settlements with a total of 502 hospitals, of which 470 hospitals (93.6%) were matched to the NCDR ICD Registry. Of these 470 hospitals, 2 hospitals were excluded because they were closed and 16 were excluded because they did not have data submitted to the registry or submitted data that did not meet NCDR quality standards.
Medicare beneficiaries ( Figure 2B ) with significant reductions at both groups of hospitals. There was a 62.9% (95% CI, 58.8% to 67.0%) relative and 16.6% (95% CI, 14.9% to 18.4%) absolute reduction at settlement hospitals and 55.8% (95% CI, 52.6% to 59.1%) relative and 12.9% (95% CI, 11.8% to 14.1%) absolute reduction at nonsettlement hospitals in the proportion of ICDs not meeting the NCD criteria among non-Medicare beneficiaries (P < .001 for both; P for interaction < .001).
Volume of Primary and Secondary Prevention ICDs in Medicare and Non-Medicare Beneficiaries
Trends in the volume of primary prevention ICDs for each 6-month interval is shown in Figure 3A . Overall, there were significant reductions in procedural volume across all hospitals with larger reductions at settlement hospitals. There was a 32.8% (95% CI, 29.9% to 35.7%) relative and 1703 (95% CI, 1520 to 1886) absolute reduction in primary prevention ICD implants at settlement hospitals compared with a 17.4% (95% CI, 14.8% to 20.0%) relative and 1495 (95% CI, 1249 to 1741) absolute decrease in primary prevention ICDs at nonsettlement hospitals (P < .001 for both; P for interaction < .001). The decrease in initial primary prevention ICD volume began before hospitals were made aware of the DOJ investigation and continued through June 2011 with relatively stable volume through the remainder of the study period. The volume of initial secondary prevention ICDs is shown in Figure 3B with a 19.1% (95% CI, 13.4% to 24.8%) relative and 334 (95% CI, 224 to 444) absolute decrease in secondary prevention ICDs at settlement hospitals and a 19.1% (95% CI, 13.2% to 25.0%) relative and 555 (95% CI, 399 to 711) absolute increase in secondary prevention ICDs at nonsettlement hospitals ( Figure 3B ). Among settlement hospitals, the decreases in secondary prevention ICDs began prior to the announcement of the investigation in 2010. Trends in the volume of primary prevention We compared the slope of the percentage of ICD implantations outside the CMS NCD during these periods for hospitals that did and did not settle and annualized the rates of change. A, The annualized rates of change for each period: before the DOJ announcement, −1.1% (95% CI, −1.7% to −0.5%) for settlement hospitals vs −0.4% (95% CI −1.0% to 0.2%) for nonsettlement hospitals (P for interaction = .10); the DOJ announcement period, −7.4% (95% CI, −8.9% to −5.9%) for settlement hospitals vs −4.7% (95% CI, −6.2% to −3.2%) for nonsettlement hospitals (P for interaction = .01); after the DOJ announcement, −0.5% (95% CI, −0.9% to −0.2%) for settlement hospitals vs −0.4% (95% CI, −0.8% to −0.1%) for nonsettlement hospitals (P for interaction = .71).
ICDs for non-Medicare beneficiaries are also similar to those for Medicare beneficiaries (eFigure 3 in the Supplement).
The volume of ICD generator changes for the end of battery life or ICD device upgrades for Medicare beneficiaries for each 6-month period at continuously participating hospitals stratified by hospital settlement group is shown in eFigure 4 in the Supplement. In contrast to volume trends observed for primary prevention ICDs, the volume of these implants increased steadily in the period prior to the announcement of the DOJ investigation and remained relatively stable in the periods following the announcement. Moreover, the volume trends for ICD generator changes and device upgrades did not vary between hospital settlement groups.
Discussion
This national study of initial primary prevention ICDs from January 2007 through December 2015 demonstrates that the proportion of implants not meeting the CMS NCD criteria decreased at all hospitals following the announcement of the DOJ investigation, with larger and more rapid reductions at settlement hospitals, and the reduction also extended to non-Medicare beneficiaries, which were not the subject of the DOJ investigation. Over the study period, there were significant reductions in the volume of primary prevention ICDs with comparatively larger reductions at settlement hospitals. In contrast, the total volume of secondary prevention devices was relatively stable over the study period with the observed reductions in procedural volume at settlement hospitals offset by increases among nonsettlement hospitals. The study interval spans a dynamic period for ICD utilization including evolving evidence and the DOJ investigation. Although concerns about potential overuse of ICDs were raised immediately following the release of the NCD criteria, 10, [22] [23] [24] [25] this analysis demonstrates that the proportion of primary prevention ICDs not meeting the NCD criteria modestly decreased from January 2007 through December 2009. This trend was accompanied by reductions in primary prevention ICD implant volume prior to the announcement of the DOJ investigation and may reflect wider adoption of the NCD criteria and clinical practice guidelines, changes in the profile of patients at risk for sudden death, hospital participation in the ICD Registry, and other quality improvement initiatives. Following the announcement of the DOJ investigation, the reductions in the proportion of ICDs not meeting the NCD criteria were larger and more rapid, and extended to nonsettlement hospitals and to ICDs among non-Medicare beneficiaries potentially reflecting broad awareness of the investigation. Despite substantial decreases in the proportion of primary prevention ICDs not meeting NCD criteria, there was persistent variation in performance at the hospital level with more than 14% of primary prevention ICDs not meeting NCD criteria at the worst-performing hospitals. Although this variation may represent opportunity for improvement, it may also reflect a gap between the NCD criteria and clinical practice. Current guidelines clarify that "the ultimate judgment about care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient. As a result, situations may arise in which deviations from these guidelines may be appropriate." 8 To that point, the DOJ acknowledged that there are legitimate clinical indications for placing an ICD that does not meet current NCD guidelines in their lawsuit resolution model given to hospitals to evaluate liability. Furthermore, CMS has updated the NCD criteria on ICDs to reflect new clinical studies and practice guidelines. 18, [26] [27] [28] [29] The need for concordance between the NCD criteria, practice guidelines, and appropriate use criteria has been the subject of ongoing discussions and warrants additional study.
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Understanding potential unintended consequences of the DOJ investigation remains an important area for further study.
The analyses of secondary prevention ICDs do not suggest that access to necessary procedures was negatively affected by the investigation and observed changes in secondary prevention ICD volume preceded the announcement. These analyses offer some reassurance, but further research into hospital responses to the investigation could offer additional insights about possible unintended consequences.
Limitations
This study has several limitations. First, this analysis may not reflect all cases among non-Medicare beneficiaries as hospitals are only required to submit data on Medicare beneficiaries for reimbursement. Nonetheless, 80% of participating hospitals report all types of ICD implantations performed for any payer. 10, 31 Second, although hospitals were stratified by inclusion in DOJ settlements, there is no public listing identifying all hospitals that were officially investigated by the DOJ. The initial whistle-blower complaint included many more hospitals than the final list of facilities who ultimately reached settlements. As such, the group of hospitals that did not settle likely includes facilities that were investigated. Third, interrupted time series analysis attributes observed changes to the single factor of interest regardless of other simultaneous changes. Many factors likely influenced practice patterns over the study period, and we cannot be certain that the observed trends are a direct result of the DOJ investigation. Fourth, because we only have information about patients that actually received ICDs, we are unable to fully assess whether the DOJ investigation was associated with any barriers to the placement of clinically indicated ICDs. 
Conclusions
